EUVIMEDEUVIMED entdecken
Crossref

Prescription medication use among patients with type 2 diabetes in the United States: 1999–2020

Shanshan Li, Shaoxi Pan, Shaoxiang Jiang, Jung-Im Shin iD, Gordon G Liu, Beini Lyu iD

Diabetes, Obesity and Metabolism · 2024-07 · 26 (7) · 2933-2944

DOI: 10.1111/dom.15619 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetes, Obesity and Metabolism, online erschienen am 02.05.2024. Verfasst von Shanshan Li und 5 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Global Health and Development, Peking University, Beijing, China. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Polypharmacy, Nutrition Surveys, Prescription Drugs. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 48 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

We aimed to examine trends in overall prescription medication use among patients with type 2 diabetes in the United States to provide insights for patient care. Materials and Methods We used nationally representative data from the National Health and Nutrition Examination Survey from 1999 to 2020 and included adult patients with type 2 diabetes. We examined the use of prescription drugs, overall and by drug class, polypharmacy (use of ≥5 medications), and number of medications attributed to specific classes.

Results

In the period 2015–2020, the mean patient age was 59.6 (51.0–70.0) years, with 46.8% (43.6–49.9) being female and 57.8% (52.8–62.8) being non‐Hispanic White. Among 9489 adults with type 2 diabetes, the prevalence of polypharmacy was high and increased from 35.1% (31.6–38.6) in 1999–2002 to 47.2% (43.7–50.7) in 2003–2006, and further to 51.1% (48.3–53.9) in 2015–2020 ( p for trend

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2PolypharmacyNutrition SurveysPrescription DrugsHumansFemaleMaleUnited StatesMiddle AgedAgedHypoglycemic AgentsDrug UtilizationPrevalenceAdult

Stichwörter der Autor:innen

antidepressantmedication usepolypharmacytype 2 diabetes

Substanzen

Prescription DrugsHypoglycemic Agents

Autor:innen und Institutionen

  • Institute for Global Health and Development, Peking University, Beijing, China.
  • China Center for Health Economic Research, Peking university, Beijing, China.
  • School of Public Health, the Key Laboratory of Environmental Pollution Monitoring and Disease Control, Ministry of Education, Guizhou Medical University, Guiyang, China.
  • Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
  • Welch Center for Prevention, Epidemiology and Clinical Research, Johns Hopkins University, Baltimore, Maryland, USA.
  • National School of Development, Peking University, Beijing, China.

ORCID-Profile: Jung-Im Shin, Beini Lyu

Zitieren

APA

Li, S., Pan, S., Jiang, S., Shin, J. I., Liu, G. G., & Lyu, B. (2024). Prescription medication use among patients with type 2 diabetes in the United States: 1999–2020. Diabetes, Obesity and Metabolism, 26(7), 2933-2944. https://doi.org/10.1111/dom.15619

Vancouver

Li S, Pan S, Jiang S, Shin JI, Liu GG, Lyu B. Prescription medication use among patients with type 2 diabetes in the United States: 1999–2020. Diabetes, Obesity and Metabolism. 2024;26(7):2933-2944. doi:10.1111/dom.15619

BibTeX
@article{Li2024,
  author = {Li, Shanshan and Pan, Shaoxi and Jiang, Shaoxiang and Shin, Jung-Im and Liu, Gordon G and Lyu, Beini},
  title = {Prescription medication use among patients with type 2 diabetes in the United States: 1999–2020},
  journal = {Diabetes, Obesity and Metabolism},
  year = {2024},
  volume = {26},
  number = {7},
  pages = {2933--2944},
  doi = {10.1111/dom.15619}
}
Kostenlos starten →